16α-Methyl-11-oxo Prednisolone

• CAT Number: R051617
• CAS Number: 2036-77-3
• Molecular Formula: C22H28O5
• Molecular Weight: 372.46
• Purity: ≥95%
• Synonyms: (16α)-17,21-Dihydroxy-16-methylpregna-1,4-diene-3,11,20-trione; Dexamethasone Impurity J
• Storage: Desiccate at -20°C
• IUPAC Name: (8S,9S,10R,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
• InChI: InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,19-,20+,21+,22+/m1/s1
• InChIKey: PIDANAQULIKBQS-VUOZLLHNSA-N
• SMILES: CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C

16α-Methyl-11-oxo prednisolone (Cat No.:R051617) is a synthetic corticosteroid compound. It is derived from prednisolone, a glucocorticoid hormone with anti-inflammatory and immunosuppressive properties. The 16α-methyl substitution enhances the compound’s metabolic stability. 16α-Methyl-11-oxo prednisolone is used in medical and pharmaceutical research for its potential as an anti-inflammatory agent. Its modified structure aims to reduce adverse effects and increase therapeutic potency compared to natural corticosteroids. This compound’s altered functional group positions contribute to its specific pharmacological properties, supporting its study and potential development as a therapeutic agent.